Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$211.4B
14,267M shares
52-week range
$9.31 – $15.00
96% from low
Exchange
NYSE
ADRC
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
www.santander.comNo one on the platform currently holds SAN.
No tracked institution reports a position in SAN as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-04 | $0.1460 | 2026-05-08 |
| 2025-10-31 | $0.1323 | 2025-11-06 |
| 2025-04-30 | $0.1241 | 2025-05-07 |
| 2024-10-31 | $0.1085 | 2024-11-06 |
| 2024-04-29 | $0.1015 | 2024-05-07 |
| 2023-10-31 | $0.0858 | 2023-11-07 |
| Execution date | Ratio |
|---|---|
| 2020-11-12 | 1.04347826-for-1 |
| 2017-10-16 | 2-for-1 |
| 2015-10-15 | 104-for-103 |
| 2015-01-09 |
No one on the platform has traded SAN yet.
| 45-for-44 |
| 2014-10-15 | 47-for-46 |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $63.4B | +2.9% | $1.04 | $0.84–$1.23 | 14.2× | 4 |
| 2027 | $69.0B | +8.8% | $1.25 | $1.00–$1.40 | 11.8× | 5 |
| 2028 | $72.0B | +4.4% | $1.45 | $0.83–$1.67 | 10.2× | 12 |
| 2029 | $73.6B | +2.1% | $1.48 | $1.43–$1.53 | 10.0× | 9 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-22 | $0.29 | $0.27 | -6.9% |
| 2026-04-29 | $0.29 | $0.41 | +42.9% |
| 2026-02-04 | $0.25 | $0.25 | +0.0% |
| 2025-10-29 | $0.25 | $0.23 | -8.0% |
| 2025-07-30 | $0.26 | $0.22 | -15.4% |
| 2025-04-30 | $0.22 | $0.22 | +0.0% |
| 2025-02-05 | $0.21 | $0.21 | +1.7% |
| 2024-10-29 | $0.22 |
| $0.22 |
| +0.0% |
| $94.7B |
| — |
| CCitigroup Inc. | $138.73 | +0.84% | $237.9B | — |
| HSBCHSBC Holdings plc | $104.05 | -0.07% | $357.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$SAN printed a new 52-week high today
View on StockTwits ↗$IBM $SAP $NVO $AMGN $SAN IBM expands enterprise AI and hybrid cloud, SAP leads enterprise software, Novo Nordisk dominates obesity treatments, Amgen advances biotechnology, and Banco Santander benefits from international banking.
View on StockTwits ↗$SAN printed a new 52-week high today
View on StockTwits ↗Stocks hitting new 52-week highs today: $SAN $ET $RELY $FAST $AEG A broad group of sectors are showing strength: Financials Industrials Healthcare Aerospace Energy Consumer When multiple sectors are making new highs, it can signal broader market participation beyond just a handful of mega-cap names. The key is identifying which companies have the fundamentals and growth catalysts to continue the trend. Follow my profile for more market trends, stock ideas, and investment insights. NFA. DYOR.
View on StockTwits ↗$SAN printed a new 52-week high today
View on StockTwits ↗$IBM $SAP $NVO $AMGN $SAN IBM expands enterprise AI and hybrid cloud, SAP leads enterprise software, Novo Nordisk dominates obesity treatments, Amgen advances biotechnology, and Banco Santander benefits from international banking.
View on StockTwits ↗$SAN printed a new 52-week high today
View on StockTwits ↗$IBM $SAP $NVO $AMGN $SAN IBM expands enterprise AI and hybrid cloud, SAP leads enterprise software, Novo Nordisk dominates obesity treatments, Amgen advances biotechnology, and Banco Santander benefits from international banking.
View on StockTwits ↗$SAN The company is developing engineered cell therapies for major diseases such as type 1 diabetes, autoimmune diseases, and cancer. Even one successful therapy could address a multi-billion-dollar market..
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-7-22-banco-santander-sa-stock/ $SAN Banco Santander Earnings Transcript
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.